logo
Sign InSign Up

HOLOGIC INC (HOLX)

Sector: Healthcare

Financial Fundamentals

findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for HOLX, sign up here.

Income Statement

Revenue

$4.0bn

Gross Profit

$2.0bn

Earning before Tax

$628.3m

Net Income

$515.1m

Net Income Common Shareholders

$515.1m

EPS

2.12

Balance Sheet

Cash

$1.9bn

Debt

$2.6bn

Assets

$8.5bn

Liabilities

$3.8bn

Equity

$4.7bn

Enterprise Value

$17.3bn

Cash Flow Statement

Net Cash from Operations

$1.0bn

Net Cash from Investing

$-0.2bn

Net Cash from Financing

$-1.3bn

Net Cash Flow

$-0.5bn

Free Cash Flow

$858.7m

Free Cash Flow per Share

$3.60

Metrics

Price to Equity

33.29

Price to Equity (Damodaran)

33.70

Price to Book

3.69

Net Margin

0.13

Return on Equity

0.10

Return on Sales

0.19

Get immediate access to 5-years of reference grade data for HOLX for free.

Sign up

Company Profile

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women''s health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Company Info

Industry

Medical Instruments & Supplies

Employees

6,990

Address

250 Campus Drive
Marlborough, MA 01752
United States

Phone

508 263 2900

Last Updated

2024-02-08

Available Data

Standardized Financial Statements

EOD Price History

Corporate Actions

Institutional Holdings

Insider Transactions

Sign up for free and get immediate access
logo

Radically accessible financial data

Contact Info

findl.com info@findl.com

Explore findl data

DocumentationSupport

Copyright © findl 2024. All rights reserved.

Terms & Use

Privacy Policy